Your browser doesn't support javascript.
Interferon gamma runs interference on persistent COVID-19.
Elliott, Eric Isaac; Wang, Andrew.
  • Elliott EI; Yale University School of Medicine, Department of Internal Medicine (Infectious Diseases), New Haven, CT, USA.
  • Wang A; Yale University School of Medicine, Department of Internal Medicine (Rheumatology, Allergy & Immunology) and Department of Immunobiology, New Haven, CT, USA.
Med (N Y) ; 2(10): 1111-1113, 2021 10 08.
Article in English | MEDLINE | ID: covidwho-1458601
ABSTRACT
COVID-19 represents a collection of disease endotypes stemming from infection with SARS-CoV-2 and thus requires precision medicine approaches to target specific viral variants and stages of illness. In this issue, van Laarhoven et al.1 describe five immunocompromised patients with prolonged COVID-19 successfully treated with interferon gamma (IFNγ).
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Topics: Long Covid / Variants Limits: Humans Language: English Journal: Med (N Y) Year: 2021 Document Type: Article Affiliation country: J.medj.2021.09.004

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Topics: Long Covid / Variants Limits: Humans Language: English Journal: Med (N Y) Year: 2021 Document Type: Article Affiliation country: J.medj.2021.09.004